Details of Host Protein
Host Protein General Information (ID: PT0778) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
Pre-mRNA-processing factor 19 (PRPF19)
|
Gene Name |
PRPF19
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
PRP19_HUMAN
|
||||||
Protein Families |
WD repeat PRP19 family
|
||||||||
EC Number |
2.3.2.27
|
||||||||
Subcellular Location |
Nucleus; nucleoplasm Cytoplasm; cytoskeleton
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
Ubiquitin-protein ligase which is a core component of severalcomplexes mainly involved pre-mRNA splicing and DNA repair. Requiredfor pre-mRNA splicing as component of the spliceosome. Core component of the PRP19C/Prp19 complex/NTC/Nineteen complex whichis part of the spliceosome and participates in its assembly, itsremodeling and is required for its activity. During assembly of thespliceosome, mediates 'Lys-63'-linked polyubiquitination of the U4spliceosomal protein PRPF3. Ubiquitination of PRPF3 allows itsrecognition by the U5 component PRPF8 and stabilizes the U4/U5/U6 tri-snRNP spliceosomal complex. Recruited to RNApolymerase II C-terminal domain (CTD) and the pre-mRNA, it may alsocouple the transcriptional and spliceosomal machineries. The XAB2 complex, which contains PRPF19, is alsoinvolved in pre-mRNA splicing, transcription and transcription-coupledrepair. Beside its role in pre-mRNA splicing PRPF19, as part of the PRP19-CDC5L complex, plays a role in the DNA damageresponse/DDR. It is recruited to the sites of DNA damage by the RPAcomplex where PRPF19 directly ubiquitinates RPA1 and RPA2. 'Lys-63'-linked polyubiquitination of the RPA complex allows the recruitment ofthe ATR-ATRIP complex and the activation of ATR, a master regulator ofthe DNA damage response. May also play a role in DNAdouble-strand break (DSB) repair by recruiting the repair factor SETMARto altered DNA. As part of the PSO4 complex may alsobe involved in the DNA interstrand cross-links/ICLs repair process. In addition, may also mediate 'Lys-48'-linkedpolyubiquitination of substrates and play a role in proteasomaldegradation. May play a role in the biogenesis oflipid droplets. May play a role in neuraldifferentiation possibly through its function as part of thespliceosome.
[1-8]
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
Ubiquitin mediated proteolysis | hsa04120 | Pathway Map | |||||||
Spliceosome | hsa03040 | Pathway Map | |||||||
3D Structure |
|
Host Protein - Virus RNA Network | |||||||||
---|---|---|---|---|---|---|---|---|---|
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: 3'-UTR (hCoV-19/Not Specified Virus Strain ) | |||||||||
RNA Region Details | RNA Info Click to show the detail information of this RNA binding region | [9] | |||||||
Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
RNA Binding Region |
3'-UTR
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Huh7 cells (human liver cell line); Calu-3 cells (human lung cancer cell line) (CVCL_0336;CVCL_0609 ) | ||||||||
Cell Originated Tissue | Liver; Lung | ||||||||
Interaction Score | P-value < 0.05 | ||||||||
Method Description | RNA pull-down assays; liquid chromatography with tandem mass spectrometry (LC-MS/MS); Wilcoxon test; MS2 affinity purification coupled with liquid chromatography-mass spectrometry (MAMS) | ||||||||
RNA Region: Not Specified Virus Region (hCoV-19/USA/WA1/2020 ) | |||||||||
RNA Region Details | RNA Info Click to show the detail information of this RNA binding region | [10] | |||||||
Strains Name |
hCoV-19/USA/WA1/2020
|
||||||||
Strains Family |
Alpha (B.1.1.7)
|
||||||||
RNA Binding Region |
Not Specified Virus Region
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Huh7.5 cells (Hepatocyte derived cellular carcinoma cell) Huh7.5 cells (Hepatocyte derived cellular carcinoma cell) (CVCL_7927 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Infection Time | 48 h | ||||||||
Interaction Score | FDR ≤ 0.05 | ||||||||
Method Description | comprehensive identification of RNA-binding proteins by massspectrometry (ChIRP-MS) |